Signalling pathways in pemphigus vulgaris

被引:10
|
作者
Li, Xiaoguang
Ishii, Norito
Ohata, Chika
Furumura, Minao
Hashimoto, Takashi [1 ]
机构
[1] Kurume Univ, Dept Dermatol, Sch Med, 67 Asahimachi, Kurume, Fukuoka 8300011, Japan
关键词
acantholysis; pemphigus vulgaris; signalling pathway; DESMOGLEIN; 3; C-MYC; P38MAPK; DISEASE; PLAKOGLOBIN; INDUCTION; IGG; INHIBITION; DISRUPTION; ACTIVATION;
D O I
10.1111/exd.12317
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Acantholysis in pemphigus vulgaris is induced by binding of autoantibodies to desmoglein 3 (Dsg3). The roles of signalling pathways on development of acantholysis have recently been extensively studied. In the study by Sayar et al., recently published in Exp Dermatol, epidermal growth factor receptor (EGFR) signalling was activated in both in vivo and in vitro pemphigus vulgaris experimental models. However, while EGFR inhibitors suppressed activity of p38 mitogen-activated protein kinase (p38MAPK) linearly, they suppressed activity of c-Myc and acantholysis in a non-linear, V-shaped relationship. These findings indicated complicated interactions among EGFR, p38MAPK and c-Myc in pemphigus vulgaris pathology.
引用
收藏
页码:155 / 156
页数:2
相关论文
共 50 条
  • [31] Mechanism-based therapeutic targets of pemphigus vulgaris: A scoping review of pathogenic molecular pathways
    Kaur, Bavleen
    Kerbrat, Jenna
    Kho, Jia
    Kaler, Manreet
    Kanatsios, Stefanos
    Cirillo, Nicola
    EXPERIMENTAL DERMATOLOGY, 2022, 31 (02) : 154 - 171
  • [32] p38 MAPK Activation Is Downstream of the Loss of Intercellular Adhesion in Pemphigus Vulgaris
    Mao, Xuming
    Sano, Yasuyo
    Park, Jin Mo
    Payne, Aimee S.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (02) : 1283 - 1291
  • [33] An Adult Passive Transfer Mouse Model to Study Desmoglein 3 Signaling in Pemphigus Vulgaris
    Schulze, Katja
    Galichet, Arnaud
    Sayar, Beyza S.
    Scothern, Anthea
    Howald, Denise
    Zymann, Hillard
    Siffert, Myriam
    Zenhaeusern, Denise
    Bolli, Reinhard
    Koch, Peter J.
    Garrod, David
    Suter, Maja M.
    Mueller, Eliane J.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2012, 132 (02) : 346 - 355
  • [34] Transition from pemphigus vulgaris to pemphigus foliaceus: A case report
    Levy-Sitbon, C.
    Reguiai, Z.
    Durlach, A.
    Goeldel, A. -L.
    Grange, F.
    Bernard, P.
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2013, 140 (12): : 788 - 792
  • [35] What protein kinases are crucial for acantholysis and blister formation in pemphigus vulgaris? A systematic review
    Brescacin, Adriano
    Baig, Zunaira
    Bhinder, Jaspreet
    Lin, Sen
    Brar, Lovejot
    Cirillo, Nicola
    JOURNAL OF CELLULAR PHYSIOLOGY, 2022, 237 (07) : 2825 - 2837
  • [36] Deep pemphigus (pemphigus vulgaris, pemphigus vegetans and paraneoplastic pemphigus) in dogs, cats and horses: a comprehensive review
    Heng L. Tham
    Keith E. Linder
    Thierry Olivry
    BMC Veterinary Research, 16
  • [37] Pemphigus vegetans - immunopathological findings in a rare variant of pemphigus vulgaris
    Monshi, Babak
    Marker, Michael
    Feichtinger, Hans
    Schmid, Grazyna
    Kriehuber, Ernst
    Foedinger, Dagmar
    Rappersberger, Klemens
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2010, 8 (03): : 179 - 183
  • [38] The role of pentraxin 3 in pemphigus vulgaris
    Yavuz, Ibrahim Halil
    Yavuz, Goknur Ozaydin
    POSTEPY DERMATOLOGII I ALERGOLOGII, 2020, 37 (04): : 503 - 507
  • [39] Confirmation of a disease model of pemphigus vulgaris: characterization and correlation between disease parameters in 90 mice
    Holm, Thomas Lindebo
    Markholst, Helle
    EXPERIMENTAL DERMATOLOGY, 2010, 19 (08) : E158 - E165
  • [40] Desmoglein ELISA in the Diagnosis of Pemphigus and Its Correlation with the Severity of Pemphigus Vulgaris
    Mortazavi, Hossein
    Shahdi, Majid
    Amirzargar, Ali Akbar
    Naraghi, Zahra S.
    Valikhani, Mahin
    Daneshpazhooh, Maryam
    Vasheghani-Farahani, Amir
    Sedaghat, Mojtaba
    Chams-Davatchi, Cheyda
    IRANIAN JOURNAL OF ALLERGY ASTHMA AND IMMUNOLOGY, 2009, 8 (01) : 53 - 56